Latest news from ISOLPHARM
ISOLPHARM new publication on preclinical imaging
A new publication entitled “Ag-111 phantom images with Cerenkov Luminescence Imaging and digital autoradiography within the ISOLPHARM project” have just been published in the journal Applied Radiation and Isotopes. This[…]
Read moreISOLPHARM 2023 annual meeting
The ISOLPHARM project 2023 annual meeting was held at the Legnaro National Laboratories of INFN on December 21st. The four Work Packages of ADMIRAL experiment presented their progress according to[…]
Read moreA new publication for the ISOLPHARM chemistry community
The ISOLPHARM chemistry group obtained a new publication entitled “Chromatographic separation of silver-111 from neutron-irradiated palladium target: toward direct labeling of radiotracers” in the journal EJNMMI Radiopharmacy and Chemistry.Congratulations to[…]
Read moreA Large Collaboration Between Universities and Research Centers
The ISOLPHARM Project was born from the collaboration between the Departments of Pharmaceutical and Pharmacological, Department of Chemical Sciences of the University of Padova and the Legnaro National Laboratories (LNL) of the National Institute of Nuclear Physics (INFN) where the Selective Production of Exotic Specie (SPES) project in under development. By means, of Isotope Separation On-Line technique both traditional and innovative radioisotopes will be produced with high-specific activity, going beyond the state-of-art of the radioisotope production.
Read moreStrengths and key features
The key features of ISOLPHARM are: a) the presence of a strong local collaboration between INFN-LNL, INFN-PD, INFN-PV, TIFPA, UNIPD and UNIBS in many fields of research, ranging from the production of the RIBs to the employment of the radionuclides. b) the ISOL technique, which can easily provide high specific activity radionuclides. c) the INFN patent, which proves the innovation and excellence of the project. d) the low environmental and social impact, since nuclear reactors are not used for the provision of the radionuclides, which traditionally may be obtained irradiating massive amount of materials, that lately become tons of nuclear wastes.
Advantages
VERSATILITY
Production of a large set of radionuclides carrier-free and with large radionuclide purity
INNOVATIVITY
Many unconventional radioisotopes (short T 1/2) difficult to produce with traditional techniques
FLEXIBILITY
On-line mass selection by tuning the separator; easy production of different radionuclides
GREEN
Low production of radioative waste material
2023-2025 Project
ISOLPHARM_ADMIRAL
The future for radiopharmaceutical production at ISOLPHARM